First Time Loading...

SciVision Biotech Inc
TWSE:1786

Watchlist Manager
SciVision Biotech Inc Logo
SciVision Biotech Inc
TWSE:1786
Watchlist
Price: 102.5 TWD 3.64% Market Closed
Updated: May 17, 2024
Section:
 

Relative Value

The Relative Value of one SciVision Biotech Inc stock under the Base Case scenario is 63.01 TWD. Compared to the current market price of 102.5 TWD, SciVision Biotech Inc is Overvalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
63.01 TWD
Overvaluation 39%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

9.7
P/S
P/S
Price to Sales
9.7
vs History
20
vs Industry
15
Median 3Y
7
Median 5Y
7.9
Industry
2.4
Forward
6.9
More Details
39
P/E
P/E
Price to Earnings
39
vs History
14
vs Industry
15
Median 3Y
29.5
Median 5Y
30.5
Industry
23.9
Forward
22.3
More Details
25.5
P/OCF
P/OCF
Price to OCF
25.5
vs History
57
vs Industry
17
Median 3Y
25.8
Median 5Y
26.4
Industry
15.6
More Details
27.1
P/FCFE
P/FCFE
Price to FCFE
27.1
vs History
22
vs Industry
21
Median 3Y
9.3
Median 5Y
9.3
Industry
22.5
More Details
4.3
P/B
P/B
Price to Book Value
4.3
vs History
3
vs Industry
21
Median 3Y
2.4
Median 5Y
2.7
Industry
2.3
More Details
9.1
EV/S
EV/S
Enterprise Value to Sales
9.1
vs History
25
vs Industry
14
Median 3Y
6.3
Median 5Y
7.3
Industry
2.5
Forward
6.4
More Details
12.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
12.6
vs History
25
vs Industry
18
Median 3Y
9.2
Median 5Y
10.7
Industry
5.3
More Details
24.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
24.7
vs History
31
vs Industry
14
Median 3Y
18.1
Median 5Y
21.1
Industry
12.9
More Details
32.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
32.5
vs History
22
vs Industry
14
Median 3Y
24.7
Median 5Y
25.5
Industry
17.8
Forward
15.1
More Details
23.8
EV/OCF
EV/OCF
Enterprise Value to OCF
23.8
vs History
57
vs Industry
19
Median 3Y
23.1
Median 5Y
24.4
Industry
15.4
More Details
25.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
25.2
vs History
63
vs Industry
21
Median 3Y
28.1
Median 5Y
28.6
Industry
19.6
More Details
4.8
EV/IC
EV/IC
Enterprise Value to IC
4.8
vs History
3
vs Industry
19
Median 3Y
2.2
Median 5Y
2.5
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
SciVision Biotech Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
TW
SciVision Biotech Inc
TWSE:1786
6.9B TWD 9.7 39 24.7 32.5
CH
Alcon AG
SIX:ALC
39.3B CHF 4.6 44.5 19.6 39.9
JP
Hoya Corp
TSE:7741
6.6T JPY 8.8 39.8 24.2 29.9
DK
Coloplast A/S
CSE:COLO B
190.7B DKK 7.7 39.4 25.8 29.9
US
Align Technology Inc
NASDAQ:ALGN
20.6B USD 5.3 44.5 24.4 29.7
US
Cooper Companies Inc
NYSE:COO
19.5B USD 5.3 66.9 24.2 41.2
KR
HLB Inc
KOSDAQ:028300
12.4T KRW 203.1 -46.1 -107.2 -98.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
58.3B CNY 14.3 33.8 29.7 29.7
UK
ConvaTec Group PLC
LSE:CTEC
5.1B GBP 3 50 46.8 50.9
US
DENTSPLY SIRONA Inc
NASDAQ:XRAY
5.9B USD 1.5 -62 11.7 26.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.6B USD 4.1 12.2 10.2 11.5

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.